Acasti Pharma reported $20K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Addus HomeCare USD 160.87M 15.74M Sep/2026
Amarin USD 126.83M 477K Dec/2025
Cassava Sciences USD 117K 3K Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Option Care Health USD 505.57M 5.94M Sep/2026
Organigram Holdings CAD 88.6M 35.22M Jun/2026
Tilray USD 109.07M 2M Sep/2025